Aderbasib
Aderbasib (codenamed INCB7839) is a sheddase inhibitor that may suppress tumor cell proliferation.
≈ 2 min read
Aderbasib. encyclopegia.org, snapshot enwiki-001365679917. /a/aderbasib
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Aderbasib (codenamed INCB7839) is a sheddase inhibitor that may suppress tumor cell proliferation.[1] Acting on multiple receptor classes and subclasses, aderbasib is observed to regulate the tumor necrosis factor of cancer cells.[2] Aderbasib was being developed by Incyte as a potential adjunctive treatment for metastatic breast cancer. Development was halted in 2011 after positive findings from Phase II trials were contradicted by further research.[3][4]
More specifically, aderbasib is an inhibitor of ADAM10 and ADAM17.[5]
References
edit edit source- ^ "STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL" (PDF). Ama-assn.org. Retrieved 2012-10-13. Wikipedia revision 1365679917, retrieved 2026-11-18
- ^ "Aderbasib | CAS#791828-58-5". MedKoo. Retrieved 2012-10-13. Wikipedia revision 1365679917, retrieved 2026-11-18
- ^ Incyte (2011-09-19). "UBS 2011 Global Life Sciences Conference". Retrieved 2013-02-13. Wikipedia revision 1365679917, retrieved 2026-11-18
- ^ "Incyte Reports Third Quarter 2011 Financial Results And Provides Update On Key Clinical Programs" (Press release). BusinessWire. 2011-10-27. Retrieved 2013-02-13. Wikipedia revision 1365679917, retrieved 2026-11-18
- ^ Yang L, Bhattacharya A, Li Y, Sexton S, Ling X, Li F, et al. (June 2022). "Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer". Journal of Experimental & Clinical Cancer Research. 41 (1): 184. doi:10.1186/s13046-022-02389-z. PMC 9161494. PMID 35650607. Wikipedia revision 1365679917, retrieved 2026-11-18
External links
edit edit sourceText derived from https://en.wikipedia.org/w/index.php?oldid=1365679917 under CC BY-SA 4.0; modifications have been made.